This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Jump to section
Related Articles
Cited By...
- Revisiting Weight-Normalized SUV and Lean-Body-Mass-Normalized SUV in PET Studies
- Can histologic transformation of follicular lymphoma be predicted and prevented?
- Comparison of 11C-Methionine and 18F-FDG PET/CT for Staging and Follow-up of Pediatric Lymphoma
- FDG PET-CT in follicular lymphoma: a case-based evidence review
- The accuracy of positron emission tomography in the detection of posttransplant lymphoproliferative disorder
- Prognostic Value of Tumor 18F-FDG Uptake in Patients with Untreated Extranodal Natural Killer/T-Cell Lymphomas of the Head and Neck
- Imaging of Cell Proliferation: Status and Prospects
- Molecular Imaging of Proliferation in Malignant Lymphoma.
- The Role of PET in Lymphoma
- Intensity of 18Fluorodeoxyglucose Uptake in Positron Emission Tomography Distinguishes Between Indolent and Aggressive Non-Hodgkin's Lymphoma
- Role of Positron Emission Tomography in Lymphoma
- PET/CT in Oncology: Integration into Clinical Management of Lymphoma, Melanoma, and Gastrointestinal Malignancies
- PET Scans in the Staging of Lymphoma: Current Status
- Utility of FDG-PET scanning in lymphoma by WHO classification
- Usefulness of Whole-Body 18F-FDG PET in Patients with Suspected Metastatic Brain Tumors
- Effect of Whole-Body 18F-FDG PET Imaging on Clinical Staging and Management of Patients with Malignant Lymphoma
- Radiolabeled Amino Acids: Basic Aspects and Clinical Applications in Oncology
- Nodal Staging of Lymphoma with Whole-Body PET: Comparison of [11C]Methionine and FDG
- Positron Emission Tomography in Non-Hodgkin's Lymphoma: Assessment of Chemotherapy With Fluorodeoxyglucose
- Detection of Lymphoma in Bone Marrow by Whole-Body Positron Emission Tomography